Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Cash & Equivalents	353.83	344.87	358.33	161.9	341.25	268.27	Upgrade
Short-Term Investments	328.16	252.65	173.85	217.27	96.85	2.99	Upgrade
Cash & Short-Term Investments	681.99	597.52	532.18	379.17	438.1	271.26	Upgrade
Cash Growth	21.87%	12.28%	40.35%	-13.45%	61.50%	40.05%	Upgrade
Accounts Receivable	111.44	104.75	42.04	-	-	-	Upgrade
Inventory	31.04	26.51	6.99	-	-	-	Upgrade
Other Current Assets	16.88	13.27	6.71	4.61	4.17	3.8	Upgrade
Total Current Assets	841.35	742.05	587.91	383.78	442.27	275.06	Upgrade
Net Property, Plant & Equipment	158.04	161.45	168.23	169.73	119.58	34.17	Upgrade
Long-Term Investments	138.81	152.11	61.95	4.62	64.37	-	Upgrade
Other Long-Term Assets	0.2	0.23	0.26	0.32	0.07	1.61	Upgrade
Total Assets	1,138	1,056	818.36	558.45	626.3	310.84	Upgrade
Accounts Payable	7.12	4.99	4.13	3.98	8.4	2.11	Upgrade
Accrued Expenses	78.16	95.79	27.49	23.31	16.3	5.11	Upgrade
Current Portion of Leases	1.62	1.22	1.47	1.56	1.04	8.24	Upgrade
Total Current Liabilities	86.9	102	33.09	28.85	25.74	15.45	Upgrade
Long-Term Leases	8.06	6.04	6.62	7.37	6.98	3.31	Upgrade
Other Long-Term Liabilities	2.79	1.42	-	-	-	-	Upgrade
Total Long-Term Liabilities	10.85	7.46	6.62	7.37	6.98	3.31	Upgrade
Total Liabilities	97.75	109.46	39.71	36.22	32.72	18.76	Upgrade
Additional Paid-in Capital	1,146	1,127	1,048	803.72	734.52	363.29	Upgrade
Accumulated Other Comprehensive Income	1.16	-0.19	0.64	-0.73	-0.16	0.01	Upgrade
Retained Earnings	-106.6	-180.67	-269.83	-280.76	-140.78	-71.21	Upgrade
Shareholders' Equity	1,041	946.38	778.64	522.23	593.58	292.08	Upgrade
Total Liabilities & Equity	1,138	1,056	818.36	558.45	626.3	310.84	Upgrade
Total Debt	9.68	7.26	8.09	8.93	8.02	11.55	Upgrade
Net Cash (Debt)	672.31	590.26	524.08	370.24	430.07	259.72	Upgrade
Net Cash Growth	13.90%	12.63%	41.55%	-13.91%	65.59%	36.39%	Upgrade
Net Cash Per Share	22.48	19.85	18.89	14.52	19.38	13.82	Upgrade
Book Value	1,041	946.38	778.64	522.23	593.58	292.08	Upgrade
Book Value Per Share	34.79	31.82	28.06	20.49	26.74	15.55	Upgrade
Tangible Book Value	1,041	946.38	778.64	522.23	593.58	292.08	Upgrade
Tangible Book Value Per Share	34.79	31.82	28.06	20.49	26.74	15.55	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.